|
[1]LOZANO R,NAGHAVI M,FOREMAN K,et al.Global and regional mortality from 235 causes of death for 20 age groups in 1990and 2010:a systematic analysis for the Global Burden of Disease Study 2010[J].Lancet,2012,380(9859):2095-2128.
|
|
[2]SHIINA S.Image-guided percutaneous ablation therapies for hepatocellular carcinoma[J].J Gastroenterol,2009,44(Suppl 19):122-131.
|
|
[3]ROSSI S,di STASI M,BUSCARINI E,et al.Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer[J].AJR Am J Roentgenol,1996,167(3):759-768.
|
|
[4] POULOU LS,BOTSA E,THANOU I,et al.Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma[J].World J Hepatol,2015,7(8):1054-1063.
|
|
[5]IKEDA K,OSAKI Y,NAKANISHI H,et al.Recent progress in radiofrequency ablation therapy for hepatocellular carcinoma[J].Oncology,2014,87(Suppl 1):73-77.
|
|
[6]ZHOU Y,ZHAO Y,LI B,et al.Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma[J].BMC Gastroenterol,2010,10:78.
|
|
[7]XU Q,KOBAYASHI S,YE X,et al.Comparison of hepatic resection and radiofrequency ablation for small hepatocellular carcinoma:a meta-analysis of 16,103 patients[J].Sci Rep,2014,4:7252.
|
|
[8]CUCCHETTI A,PISCAGLIA F,CESCON M,et al.Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma[J].World J Gastroenterol,2013,19(26):4106-4018.
|
|
[9]MIURA JT,JOHNSTON FM,TSAI S,et al.Surgical resection versus ablation for hepatocellular carcinoma≤3 cm:a populationbased analysis[J].HPB(Oxford),2015,17(10):896-901.
|
|
[10]JIANG L,YAN L,WEN T,et al.Comparison of outcomes of hepatic resection and radiofrequency ablation for hepatocellular carcinoma patients with multifocal tumors meeting the barcelona-clinic liver cancer stage a classification[J].J Am Coll Surg,2015,221(5):951-961.
|
|
[11]XIE X,JIANG C,PENG Z,et al.Local recurrence after radiofrequency ablation of hepatocellular carcinoma:treatment choice and outcome[J].J Gastrointest Surg,2015,19(8):1466-1475.
|
|
[12]CHOI D,LIM HK,RHIM H,et al.Percutaneous radiofre-quency ablation for recurrent hepatocellular carcinoma after hepatectomy:long-term results and prognostic factors[J].Ann Surg Oncol,2007,14(8):2319-2329.
|
|
[13]CHAN AC,POON RT,CHEUNG TT,et al.Survival analysisof re-resection versus radiofrequency ablation for intrahepatic recurrence afterhepatectomy for hepatocellular carcinoma[J].World J Surg,2012,36(1):151-156.
|
|
[14]LEE DH,LEE JM,LEE JY,et al.Radiofrequency ablationfor intrahepatic recurrent hepatocellular carcinoma:long-term results andprognostic factors in 168 patients with cirrhosis[J].Cardiovasc Intervent Radiol,2014,37(3):705-715.
|
|
[15]FUKUHARA T,AIKATA H,HYOGO H,et al.Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment:comparison with primary cases[J].Eur J Radiol,2015,84(8):1540-1545.
|
|
[16]ITAMOTO T,NAKAHARA H,AMANO H,et al.Repeat hepatectomy for recurrent hepatocellular carcinoma[J].Surgery,2007,141(5):589-597.
|
|
[17]WU CC,CHENG SB,YEH DC,et al.Second and third hepatectomies forrecurrent hepatocellular carcinoma are justified[J].Br J Surg,2009,96(9):1049-1057.
|
|
[18]NEELEMAN N,ANDERSSON R.Repeated liver resection for recurrent liver cancer[J].Br J Surg,1996,83(7):893-901.
|
|
[19]FABER W,SEEHOFER D,NEUHAUS P,et al.Repeated liver resection for recurrent hepatocellular carcinoma[J].J Gastroenterol Hepatol,2011,26(7):1189-1194.
|
|
[20]HANAZAKI K,KAJIKAWA S,SHIMOZAWA N,et al.Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma[J].J Am Coll Surg,2000,191(4):381-388.
|
|
[21]SHIMADA M,TAKENAKA K,GION T,et al.Prognosis of recurrent hepatocellular carcinoma:a 10-year surgical experience in Japan[J].Gastroenterology,1996,111(3):720-726.
|
|
[22]SONG KD,LIM HK,RHIM H,et al.Repeated hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma after hepatic resection:a propensity score matching study[J].Radiology,2015,275(2):599-608.
|
|
[23]CAI H,KONG W,ZHOU T,et al.Radiofrequency ablation versus reresection in treating recurrent hepatocellular carcinoma[J].Medicine(Baltimore),2014,93(22):e122.
|
|
[24]INOUE T,MINAMI Y,CHUNG H,et al.Radiofrequency ablation for hepatocellular carcinoma:assistant techniques for difficult cases[J].Oncology,2010,78(Suppl 1):94-101.
|
|
[25]TATEISHI R,SHIINA S,TERATANI T,et al.Percutaneous radiofrequency ablation for hepatocellular carcinoma.An analysis of1000 cases[J].Cancer,2005,103(6):1201-1209.
|
|
[26]CHOPRA S,DODD GD,CHANIN MP,et al.Radiofrequency ablation of hepatic tumors adjacent to the gallbladder:feasibility and safety[J].AJR Am J Roentgenol,2003,180(3):697-701.
|
|
[27]CHOI D,LIM HK,KIM MJ,et al.Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract[J].AJR Am J Roentgenol,2004,183(5):1417-1424.
|
|
[28]KODA M,UEKI M,MAEDA Y,et al.Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm[J].AJR Am J Roentgenol,2004,183(3):583-588.
|
|
[29]YANG W,YAN K,WU G,et al.Radiofrequency ablation of hepatocellular carcinoma in difficult locations:strategies and long-term outcomes[J].World J Gastroenterol,2015,21(5):1554-1566.
|
|
[30] LIVRAGHI T,SOLBIATI L,MELONI MF,et al.Treatment of focal liver tumors with percutaneous radio-frequency ablation:complications encountered in a multicenter study[J].Radiology,2003,226(2):441-451.
|
|
[31]TERATANI T,YOSHIDA H,SHIINA S,et al.Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations[J].Hepatology,2006,43(5):1101-1108.
|
|
[32]MULIER S,MULIER P,NI Y,et al.Complications of radiofrequency coagulation of liver tumours[J].Br J Surg,2002,89(10):1206-1222.
|
|
[33] RHIM H,YOON KH,LEE JM,et al.Major complications after radio-frequency thermal ablation of hepatic tumors:spectrum of imaging findings[J].Radiographics,2003,23(1):123-134.
|
|
[34]CHENG AL,KANG YK,CHEN Z,et al.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma:a phaseⅢrandomised,double-blind,placebocontrolled trial[J].Lancet Oncol,2009,10(1):25-34.
|
|
[35] LLOVET JM,RICCI S,MAZZAFERRO V,et al.Sorafenib in advanced hepatocellular carcinoma[J].N Engl J Med,2008,359(4):378-390.
|
|
[36]LU LC,CHENG AL,POON RTP.Recent advances in the prevention of hepatocellular carcinoma recurrence[J].Semin Liver Dis,2014,34(4):427-434.
|
|
[37]FENG X,XU R,DU X,et al.Combination therapy with sorafenib and radiofrequency ablation for BCLC stage 0-B1 hepatocellular carcinoma:a multicenter retrospective cohort study[J].Am J Gastroenterol,2014,109(12):1891-1899.
|
|
[38]BRUIX J,TAKAYAMA T,MAZZAFERRO V,et al.Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation(STORM):a phase 3,randomised,double-blind,placebo-controlled trial[J].Lancet Oncol,2015,16(13):1344-1354.
|
|
[39]BENSON AB 3rd,ABRAMS TA,BEN-JOSEF E,et al.NCCN clinical practice guidelines in oncology:hepatobiliary cancers[J].J Natl Compr Cancer Netw,2009,7(4):350-391.
|
|
[40]OMATA M,LESMANA LA,TATEISHI R,et al.Asian Pacific Association for the Study of the Liverconsensus recommendations on hepatocellular carcinoma[J].Hepatol Int,2010,4(2):439-474.
|
|
[41]LLOVET JM,REAL MI,MONTAAX,et al.Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:a randomised controlled trial[J].Lancet,2002,359(9319):1734-1739.
|
|
[42]LO CM,NGAN H,TSO WK,et al.Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma[J].Hepatology,2002,35(5):1164-1171.
|
|
[43]LOVET JM,BRUIX J.Systematic review of randomized trials for unresectable hepatocellular carcinoma:chemoembolization improves survival[J].Hepatology,2003,37(2):429-442.
|
|
[44]YIN X,ZHANG L,WANG YH,et al.Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate(BCLC B)hepatocellular carcinoma[J].BMC Cancer,2014,14:849.
|
|
[45]IEZZI R,POMPILI M,la TORRE MF,et al.Radiofrequency ablation plus drug-eluting beads transcatheterarterial chemoembolization for the treatment of single largehepatocellular carcinoma[J].Dig Liver Dis,2015,47(3):242-248.
|
|
[46]WANG C,LU Y,CHEN Y,et al.Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argonhelium cryoablation:a prospective study[J].Clin Exp Metastasis,2009,26(7):839-848.
|
|
[47]YANG Y,WANG C,LU Y,et al.Outcomes of ultrasoundguided percutaneous argon-helium cryoablation of hepatocellular carcinoma[J].J Hepatobil Pancreat Sci,2012,19(6):674-684.
|
|
[48]WANG C,WANG H,YANG W,et al.Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma[J].Hepatology,2015,61(5):1579-1590.
|
|
[49]LIANG P,YU J,LU MD,et al.Practice guidelines for ultrasoundguided percutaneous microwave ablation for hepatic malignancy[J].World J Gastroenterol,2013,19(33):5430-5438.
|
|
[50]LIANG P,WANG Y,YU X,et al.Malignant liver tumors:treatment with percutaneous microwave ablation-complications among cohort of 1136 patients[J].Radiology,2009,251(13):933-940.
|
|
[51]LIANG P,YU J,YU XL,et al.Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer:a multicentre analysis of 1363 treatment-naive lesions in 1007 patients in China[J].Gut,2012,61(7):1100-1101.
|
|
[52]POULOU LS,BOTSA E,THANOU I,et al.Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma[J].World J Hepatol,2015,7(8):1054-1063.
|
|
[53]SCHEFFER HJ,NIELSEN K,de JONG MC,et al.Irreversible electroporation for nonthermal tumor ablation in the clinical setting:a systematic review of safety and efficacy[J].J Vasc Interv Radiol,2014,25(7):997-1011.
|
|
[54]NARAYANAN G,FROUD T,SUTHAR R,et al.Irreversible electroporation of hepatic malignancy[J].Semin Intervent Radiol,2013,30(1):67-73.
|
|
[55]WU J,CHEN P,XIE YG,et al.Comparison of the effectiveness and safety of ultrasound-and CT-guided percutaneous radiofrequency ablation of non-operation hepatocellular carcinoma[J].Pathol Oncol Res,2015,21(3):637-642.
|
|
[56]KIM J,YOON CJ,SEONG NJ,et al.Fluoroscopy-guided radiofrequency ablation for small hepatocellular carcinoma:a retrospective comparison with ultrasound-guided ablation[J].Clin Radiol,2015,70(9):1009-1015.
|
|
[57]CHAN AK,HEGARTY C,KLASS D,et al.The role of contrastenhanced ultrasound in guiding radiofrequency ablation of hepatocellular carcinoma:a retrospective study[J].Can Assoc Radiol J,2015,66(2):171-178.
|
|
[58]TOSHIKUNI N,TSUTSUMI M,TAKUMA Y,et al.Real-time image fusion for successful percutaneous radiofrequency ablation of hepatocellular carcinoma[J].J Ultrasound Med,2014,33(11):2005-2010.
|
|
[59]LEE CH,CHEN WT,LIN CC,et al.Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations[J].Kaohsiung J Med Sci,2015,31(8):413-419.
|
|
[60]LIN ZY,SONG QQ,CHEN J,et al.Local curative effect of MRIguided radiofrequency ablation on small hepatocellular carcinoma[J].Tumour Biol,2015,36(3):2105-2110.
|
|
[61]KOETHE Y,XU S,VELUSAMY G,et al.Accuracy and efficacy of percutaneous biopsy and ablation using robotic assistance under computed tomography guidance:a phantom study[J].Eur Radiol,2014,24(3):723-730.
|
|
[62]ABDULLAH BJ,YEONG CH,GOH KL,et al.Robot-assisted radiofrequency ablation of primary and secondary liver tumours:early experience[J].Eur Radiol,2014,24(1):79-85.
|
DownLoad: